Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duchenne muscular dystrophy steroid regimen optimization trial
2010-023744-33Phase 3Unknown
- Sponsor
- University of Rochester
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of deflazacort and prednisone in Duchenne muscular dystrophy (DMD) (3 arms), sponsored by University of Rochester. Primary endpoints: Time to rise from floor, Forced vital capacity and 1 more. Status: unknown.
02
Drugs
deflazacortprednisone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2010-023744-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023744-33.